Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06064578 · ClinicalTrials.gov registry record · NA

The Ukrainian Student Problem Solving Project

A NA study, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
778
Enrollment target

NCT06064578: Completed NA study, sponsored by Harvard University.

NCT06064578 is a NA study that has completed, run by Harvard University. The registered enrollment target is 778 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06064578, a NA study, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
778 participants
Enrollment target

Study Summary

The purpose of this study is to test the effectiveness of a universal, digital, single-session intervention for youth mental health, functioning, and well-being. The investigators will be providing access to a brief online program (Project SOLVE) for students as part of the school curriculum. Ukrainian students living in Poland will be randomly assigned to receive Project SOLVE either immediately or after 3 months. The program is designed to help students manage stress and reach their academic and personal goals by teaching them how to solve problems systematically. The investigators would like to evaluate the effectiveness of this intervention in improving students' mental health and well-being.

Primary Outcome

Trajectories of self-reported symptoms of anxiety and depression from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Internalizing subscale of the Behavior and Feelings Survey. Total scores range from 0 to 24, with higher scores indicating more symptoms.

Interventions

  • BEHAVIORAL Project SOLVE

Trial Details

FieldValue
Enrollment Target 778 participants
Start Date 2023-10-15
Est. Completion 2024-06-30
Phase NA
Harvard University

37 total trials

What the finished NCT06064578 record still lists

NCT06064578 is an interventional study that assigns participants to a tested intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).

The record links to 0 conditions, and to 1 intervention - of which Project SOLVE is the first listed.

NCT06064578 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06064578 about?

NCT06064578 is a clinical study titled "The Ukrainian Student Problem Solving Project". The purpose of this study is to test the effectiveness of a universal, digital, single-session intervention for youth mental health, functioning, and well-being. The investigators will be providing access to a brief online program (Project SOLVE) for students as part of the school curriculum. Ukrain...

What is the current status of trial NCT06064578?

This trial is currently completed. It is a NA study. The enrollment target is 778 participants. The study started on 2023-10-15. Estimated completion is 2024-06-30.

What interventions are being tested in trial NCT06064578?

The interventions under investigation include: Project SOLVE (BEHAVIORAL).

Who is sponsoring clinical trial NCT06064578?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06064578's enrollment target sits among peer trials

778 142nd of 2000 higher than 1,859 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06841679 · 778 participants · Phase 2

    Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

  • NCT05642611 · 777 participants · Phase 3

    Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06064578, the US trial registry maintained by the National Library of Medicine. NCT06064578 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.